Congress Questions Bihar Minister’s Role in Fake Medicine Case

IO_AdminAfrica20 hours ago5 Views

Quick Summary

  • Congress spokesperson Supriya Shrinate criticized Bihar Urban Development Minister Jivesh Mishra, a BJP leader, for his conviction in a 15-year-old fake medicine case.
  • She argued that Mr.Mishra’s continued presence in the Cabinet reflects a moral crisis in governance and public life.
  • Mr. Mishra was convicted on June 4,2025,by a Rajasthan court for manufacturing and distributing adulterated medicines through his pharmaceutical company Alto Health Care Private Limited.
  • The substandard drugs included Ciproline-500 tablets which failed to meet prescribed quality standards during an inspection in Rajsamand district of rajasthan.
  • Despite being found guilty under Sections of the Drugs and Cosmetics Act, he was granted relief under the Probation of Offenders Act (Sections 4 & 5) with probation and fines instead of jail time due to his status as a first-time offender.
  • Ms.Shrinate raised concerns about compromised public health from such incidents and demanded Mr.Mishra’s resignation on moral grounds while urging action from the Union Health ministry and Drug Control Authority.
  • She stated that accountability must be established to prevent further deterioration in medicine quality or misuse of political positions for impunity.

Indian Opinion Analysis
The conviction of Minister Jivesh Mishra for distributing substandard medicines raises serious questions about accountability among those holding public office in India’s governance structures. In cases where public health is directly affected by regulatory lapses or malpractice, proactive measures are essential both legally and politically to ensure justice is served-not only through penalties but also via symbolic resignations when ethical breaches occur at higher levels.

The case underscores systemic issues related to drug regulations within the healthcare sector while showcasing potential gaps between legal frameworks aimed at reform versus deterrence among offenders operating large-scale entities like pharmaceutical companies. Furthermore, this specific instance may set important precedents about how individual actions-be it ministerial oversights or corporate misconduct-shape perceptions around trustworthiness within India’s political landscape amidst broader concerns surrounding law enforcement efficacy.

both immediate responses from authorities (e.g., Union Health Ministry) alongside obvious criteria on leadership ethics would likely influence long-term standards governing administrative roles linked with criminal convictions thereby upholding institutional credibility critical towards public safety assurance reforms.

Read more: Link Images attached below:

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.